![Philippe Lopes-Fernandes](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Philippe Lopes-Fernandes
Corporate Officer/Principal at
IPSEN
Profile
Philippe Lopes-Fernandes is currently Director at Histide AG, Chief Business Officer & Executive Vice President at Ipsen SA since 2020, and Industry Advisor at Agent Capital LLC.
Formerly, Mr. Lopes-Fernandes was Director at Bakx Therapeutics, Inc. and SVP & Head-Business Development at Merck KGaA. Education includes an undergraduate degree from Institut Supérieur de Gestion, conferred in 1994.
Philippe Lopes-Fernandes active positions
| Companies | Position | Start |
|---|---|---|
| IPSEN | Corporate Officer/Principal | 2020-09-30 |
Histide AG
 Histide AG Internet Software/ServicesTechnology Services Operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents | Director/Board Member | - |
Agent Capital LLC
 Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Consultant / Advisor | - |
Former positions of Philippe Lopes-Fernandes
| Companies | Position | End |
|---|---|---|
Bakx Therapeutics, Inc.
 Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Director/Board Member | - |
| MERCK KGAA | Corporate Officer/Principal | - |
Training of Philippe Lopes-Fernandes
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
35
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
Ipsen SA
 Ipsen SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Institut Supérieur de Gestion
 Institut Supérieur de Gestion Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Agent Capital LLC
Agent Capital LLC Investment ManagersFinance Agent Capital invests in companies located in the United States. The firm targets companies operating in the fields of therapeutics sectors and industries. It provides financing for seed, early, late stage, crossover and PIPE stage requirements. The firm acts as a lead investor and also makes co-investments. | Finance |
Histide AG
Histide AG Internet Software/ServicesTechnology Services Operates as a biotech intellectual property platform for non-mutagenic extracellular therapeutic agents | Technology Services |
Bakx Therapeutics, Inc.
Bakx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel cancer therapeutics | Health Technology |
- Stock Market
- Insiders
- Philippe Lopes-Fernandes
